Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 2, 2007, Pages 94-99

  Yoon, Jin Sook ^a   Ma, Kyoung Tak ^a   Kim, Sung Joo ^b   Kook, Kyunghoon ^c   Lee, Sang Yeul ^a,d  

^a Yonsei University College of Medicine   (South Korea)

^b Konyang University   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; EYE ADNEXA LYMPHOPROLIFERATIVE DISEASE; EYE DISEASE; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; KOREA; LOG RANK TEST; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NATURAL KILLER T CELL; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL ANALYSIS; SURVIVAL RATE; T CELL LYMPHOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; KILLER CELLS, NATURAL; KOREA; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; ORBITAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34247148864     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e318030b058     Document Type: Article

References (32)

1. Jakobiec FA, Mclean I, Font RL. Clinicopathologic characteristics of orbital lymphoid hyperplasia. Ophthalmology 1979;86:948-66.
2. Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): A prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990;21:959-73.
3. Auw-Haedrich C, Coupland SE, Kapp A, et al. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European American Lymphoma. Br J Ophthalmol 2001;85:63-9.
4. Lee JL, Kim MK, Lee KH, et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 2005;84:13-8.
5. Cho EY, Han JJ, Ree HJ, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 2003;73:87-96.
6. White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 1995;102:1994-2006.
7. Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 1998;105:1430-41.
8. Cahill M, Barnes C, Moriarty P, et al. Ocular adnexal lymphoma - comparison of MALT lymphoma with other histological types. Br J Ophthalmol 1999;83:742-7.
9. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000;95:802-6.
10. Sullivan TJ, Whitehead K, Williamson R, et al. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients. Ophthal Plast Reconstr Surg 2005;21:177-88.
11. Ellis JH, Banks PM, Campbell RJ, Liesegang TJ. Lymphoid tumors of the ocular adnexa. Clinical correlation with the working formulation classification and immunoperoxidase staining of paraffin sections. Ophthalmology 1985;92:1311-24.
12. Jenkins C, Rose GE, Bunce C, et al. Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye 2003;17:809-20.
13. Martinet S, Ozsahin M, Belkacemi Y, et al. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:892-8.
14. Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal zone, B cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multi-institutional, retrospective review of 50 patients. Cancer 2003;98:865-71.
15. Mannami T, Yoshino T, Oshima K, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001:14;641-9.
16. Nakata M, Matsuno Y, Katsumata N, et al. Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphoma. Leuk Lymphoma 1999;32:533-43.
17. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during 21-year period: Origins and locations. Jpn J Ophthalmol 2005;49:49-55.
18. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Cancer 1998;83:806-12.
19. Baldini L, Blini M, Guffanti A, et al. Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol 1998;9:779-81.
20. Park IS, Lee YC, Park HJ, et al. Helicobacter pylori infection in Korea. Yonsei Med J 2001;42:457-70.
21. Petrella T, Bron A, Foulet A, et al. Report of a primary lymphoma of the conjunctiva: A lymphoma of MALT origin? Pathol Res Pract 1991;187:78-84.
22. Hahn JS, Kim YS, Lee YC, et al. Eleven-year experience of low grade lymphoma in Korea (based on REAL classification). Yonsei Med J 2003;44:757-70.
23. Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 2003;57:1382-91.
24. Zinzani PL, Magagnoli M, Galieni P, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254-58.
25. Fisher RI, Dahlberg S, Nathwani BN, et al. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B cell subcategories): a Southwest Oncology Group study. Blood 1995;85:1075-82.
26. Le QT, Eulau SM, George TI, et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 2002;52:657-63.
27. Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005;11:3349-52.
28. Matsuo T, Yoshino T. Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma. Ophthalmology 2004;111:1233-7.
29. Takenaka R, Tomoda J, Sakata T, et al. Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol 2000;15:331-5.
30. Shields CL, Shields JA, Carvalho C, et al. Conjunctival lymphoid tumors: Clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology 2001:108;979-84.
31. Lee SS, Cho KJ, Kim CW, Kang YK. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms. Histopathology 1999;35:345-54.
32. Bolek TW, Moyses HM, Marcus RB Jr, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999;44:31-6.